666
Views
20
CrossRef citations to date
0
Altmetric
Articles

A multi-omics approach reveals mechanisms of nanomaterial toxicity and structure–activity relationships in alveolar macrophages

, ORCID Icon, , , , , , , , , ORCID Icon, & ORCID Icon show all
Pages 181-195 | Received 19 Jul 2019, Accepted 21 Oct 2019, Published online: 27 Nov 2019

References

  • Arts, J. H. E., M. Hadi, M-A. Irfan, A.M. Keene, R. Kreiling, D. Lyon, M. Maier, et al. 2015. “A Decision-Making Framework for the Grouping and Testing of Nanomaterials (DF4nanoGrouping).” Regulatory Toxicology and Pharmacology 71 (2): S1–S27. doi:10.1016/j.yrtph.2015.03.007.
  • Arts, J. H., M. A. Irfan, A. M. Keene, R. Kreiling, D. Lyon, M. Maier, K. Michel, et al. 2016. “Case Studies Putting the Decision-Making Framework for the Grouping and Testing of Nanomaterials (DF4nanoGrouping) into Practice.” Regulatory Toxicology and Pharmacology 76: 234–261. doi:10.1016/j.yrtph.2015.11.020.
  • Delaval, M., W. Wohlleben, R. Landsiedel, A. Baeza-Squiban, and S. Boland. 2017. “Assessment of the Oxidative Potential of Nanoparticles by the Cytochrome c Assay: Assay Improvement and Development of a High-Throughput Method to Predict the Toxicity of Nanoparticles.” Archives of Toxicology 91 (1): 163–177. doi:10.1007/s00204-016-1701-3.
  • Dierck, K., K. Machida, B. J. Mayer, and P. Nollau. 2009. Profiling the Tyrosine Phosphorylation State Using SH2 Domains. Phospho-Proteomics, 131–155. New York: Springer.
  • Donaldson, K., R. Aitken, L. Tran, V. Stone, R. Duffin, G. Forrest, and A. Alexander. 2006. “Carbon Nanotubes: A Review of Their Properties in Relation to Pulmonary Toxicology and Workplace Safety.” Toxicological Sciences 92 (1): 5–22. doi:10.1093/toxsci/kfj130.
  • Dong, J., and Q. Ma. 2015. “Advances in Mechanisms and Signaling Pathways of Carbon Nanotube Toxicity.” Nanotoxicology 9 (5): 658–676. doi:10.3109/17435390.2015.1009187.
  • Driessen, M. D., S. Mues, A. Vennemann, B. Hellack, A. Bannuscher, V. Vimalakanthan, C. Riebeling, et al. 2015. “Proteomic Analysis of Protein Carbonylation: A Useful Tool to Unravel Nanoparticle Toxicity Mechanisms.” Particle and Fibre Toxicology 12 (1): 36. doi:10.1186/s12989-015-0108-2.
  • Feliu, N., B. Pelaz, Q. Zhang, P. Del Pino, A. Nystrom, and W. J. Parak. 2016. “Nanoparticle Dosage-a Nontrivial Task of Utmost Importance for Quantitative Nanosafety Research.” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8 (3): 479–492. doi:10.1002/wnan.1378.
  • Gallud, A., K. Klöditz, J. Ytterberg, N. Östberg, S. Katayama, T. Skoog, V. Gogvadze, et al. 2019. “Cationic Gold Nanoparticles Elicit Mitochondrial Dysfunction: A Multi-Omics Study.” Scientific Reports 9 (1): 4366. doi:10.1038/s41598-019-40579-6.
  • Gerloff, K., B. Landesmann, A. Worth, S. Munn, T. Palosaari, and M. Whelan. 2017. “The Adverse Outcome Pathway Approach in Nanotoxicology.” Computational Toxicology 1: 3–11. doi:10.1016/j.comtox.2016.07.001.
  • Hsieh, S. F., D. Bello, D. F. Schmidt, A. K. Pal, A. Stella, J. A. Isaacs, and E. J. Rogers. 2013. “Mapping the Biological Oxidative Damage of Engineered Nanomaterials.” Small 9 (9–10): 1853–1865. doi:10.1002/smll.201201995.
  • Hughes, C. S., S. Foehr, D. A. Garfield, E. E. Furlong, L. M. Steinmetz, and J. Krijgsveld. 2014. “Ultrasensitive Proteome Analysis Using Paramagnetic Bead Technology.” Molecular Systems Biology 10 (10): 757. doi:10.15252/msb.20145625.
  • Hughes, C. S., S. Moggridge, T. Muller, P. H. Sorensen, G. B. Morin, and J. Krijgsveld. 2018. “Single-Pot, Solid-Phase-Enhanced Sample Preparation for Proteomics Experiments.” *Nature Protocols. doi:10.1038/s41596-018-0082-x.
  • Kroll, A., C. Dierker, C. Rommel, D. Hahn, W. Wohlleben, C. Schulze-Isfort, C. Göbbert, et al. 2011. Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays. Particle and Fibre Toxicology. 8, 9. doi:10.1186/1743-8977-8-9.
  • Krug, H. F. 2014. “Nanosafety Research—Are We on the Right Track?” Angewandte Chemie International Edition 53: 12304–12319. doi:10.1002/anie.201403367.
  • Landsiedel, R., E. Fabian, L. Ma-Hock, B. Van Ravenzwaay, W. Wohlleben, K. Wiench, and F. Oesch. 2012. “Toxico-/Biokinetics of Nanomaterials.” Archives of Toxicology 86 (7): 1021–1060. doi:10.1007/s00204-012-0858-7.
  • Landsiedel, R., L. Ma-Hock, T. Hofmann, M. Wiemann, V. Strauss, S. Treumann, W. Wohlleben, S. Groters, K. Wiench, and B. Van Ravenzwaay. 2014. “Application of Short-Term Inhalation Studies to Assess the Inhalation Toxicity of Nanomaterials.” Particle and Fibre Toxicology 11 (1): 16. doi:10.1186/1743-8977-11-16.
  • Langfelder, P., and S. Horvath. 2008. “WGCNA: An R Package for Weighted Correlation Network Analysis.” BMC Bioinformatics 9 (1): 559. doi:10.1186/1471-2105-9-559.
  • Li, N., T. Xia, and A. E. Nel. 2008. “The Role of Oxidative Stress in Ambient Particulate Matter-Induced Lung Diseases and Its Implications in the Toxicity of Engineered Nanoparticles.” Free Radical Biology and Medicine 44 (9): 1689–1699. doi:10.1016/j.freeradbiomed.2008.01.028.
  • Lin, Z., L. Ma, Z. G. X, H. Zhang, and B. Lin. 2013. “A Comparative Study of Lung Toxicity in Rats Induced by Three Types of Nanomaterials.” Nanoscale Research Letters 8 (1): 521. doi:10.1186/1556-276X-8-521.
  • Louro, H. 2018. “Relevance of Physicochemical Characterization of Nanomaterials for Understanding Nano-Cellular Interactions.” Advances in Experimental Medicine and Biology 1048: 123–142.
  • Love, M. I., W. Huber, and S. Anders. 2014. “Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2.” Genome Biology 15 (12): 550. doi:10.1186/s13059-014-0550-8.
  • Lujan, H., and C. M. Sayes. 2017. “Cytotoxicological Pathways Induced after Nanoparticle Exposure: Studies of Oxidative Stress at the 'Nano-Bio' Interface.” Toxicology Research 6 (5): 580–594. doi:10.1039/C7TX00119C.
  • Mcshan, D., P. C. Ray, and H. Yu. 2014. “Molecular Toxicity Mechanism of Nanosilver.” Journal of Food and Drug Analysis 22 (1): 116–127. doi:10.1016/j.jfda.2014.01.010.
  • Nath Roy, D., R. Goswami, and A. Pal. 2017. “Nanomaterial and Toxicity: What Can Proteomics Tell us about the Nanotoxicology?” Xenobiotica 47 (7): 632–643. doi:10.1080/00498254.2016.1205762.
  • Nel, A., T. Xia, L. Mädler, and N. Li. 2006. “Toxic Potential of Materials at the Nanolevel.” Science 311 (5761): 622–627. doi:10.1126/science.1114397.
  • Oberdörster, G., E. Oberdörster, and J. Oberdörster. 2005. “Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles.” Environmental Health Perspectives 113 (7): 823–839. doi:10.1289/ehp.7339.
  • OECD. 2012., Proposal for a template and guidance on developing and assessing the completeness of adverse outcome pathways.
  • OECD. 2018. Report on considerations from case studies on integrated approaches for testing and assessment (IATA), ENV/JM/MONO(2018)25, Series on Testing and Assessment No. 289.
  • Olson, H., G. Betton, D. Robinson, K. Thomas, A. Monro, G. Kolaja, P. Lilly, et al. 2000. “Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals.” Regulatory Toxicology and Pharmacology 32 (1): 56–67. doi:10.1006/rtph.2000.1399.
  • Pei, G., L. Chen, and W. Zhang. 2017. “WGCNA Application to Proteomic and Metabolomic Data Analysis.” Methods in Enzymology 585: 135–158. doi:10.1016/bs.mie.2016.09.016.
  • Potratz, S., P. Tarnow, H. Jungnickel, S. Baumann, M. Von Bergen, T. Tralau, and A. Luch. 2017. “Combination of Metabolomics with Cellular Assays Reveals New Biomarkers and Mechanistic Insights on Xenoestrogenic Exposures in MCF-7 Cells.” Chemical Research in Toxicology 30 (4), 883–892. doi:10.1021/acs.chemrestox.6b00106.
  • Rahi, A., N. Sattarahmady, and H. Heli. 2014. “Toxicity of Nanomaterials-Physicochemical Effects.” Austin Journal of Nanomedicine & Nanotechnology 2: 1034–1042.
  • Riebeling, C., H. Jungnickel, A. Luch, and A. Haase. 2017. “Systems Biology to Support Nanomaterial Grouping.” Advances in Experimental Medicine and Biology 947: 143–171.
  • Sandberg, A., R. M. M. Branca, J. Lehtiö, and J. Forshed. 2014. “Quantitative Accuracy in Mass Spectrometry Based Proteomics of Complex Samples: The Impact of Labeling and Precursor Interference.” Journal of Proteomics 96: 133–144. doi:10.1016/j.jprot.2013.10.035.
  • Scala, G., P. Kinaret, V. Marwah, J. Sund, V. Fortino, and D. Greco. 2018. “Multi-Omics Analysis of Ten Carbon Nanomaterials Effects Highlights Cell Type Specific Patterns of Molecular Regulation and Adaptation.” NanoImpact 11: 99–108. doi:10.1016/j.impact.2018.05.003.
  • Shanks, N., R. Greek, and J. Greek. 2009. “Are Animal Models Predictive for Humans?” Philosophy, Ethics, and Humanities in Medicine 4 (1): 2–2. doi:10.1186/1747-5341-4-2.
  • Shatkin, J. A., and K. J. Ong. 2016. “Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis.” Risk Analysis. 36: 1564–1580. doi:10.1111/risa.12642.
  • Stark, W. J., P. R. Stoessel, W. Wohlleben, and A. J. C. S. R. Hafner. 2015. “Industrial Applications of Nanoparticles.” Chemical Society Reviews. 44: 5793–5805. doi:10.1039/C4CS00362D.
  • Taurozzi, J. S., V. A. Hackley, and M. R. Wiesner. 2011. “Ultrasonic Dispersion of Nanoparticles for Environmental, Health and Safety Assessment–Issues and Recommendations.” Nanotoxicology 5 (4): 711–729. doi:10.3109/17435390.2010.528846.
  • Tee, J. K., C. N. Ong, B. H. Bay, H. K. Ho, and D. T. Leong. 2016. “Oxidative stress by inorganic nanoparticles.” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8, 414–438. doi:10.1002/wnan.1374.
  • Thompson, A., J. Schafer, K. Kuhn, S. Kienle, J. Schwarz, G. Schmidt, T. Neumann, R. Johnstone, A. K. Mohammed, and C. Hamon. 2003. “Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS.” Analytical Chemistry 75 (8): 1895–1904. doi:10.1021/ac0262560.
  • Wall, R. J., and M. Shani. 2008. “Are Animal Models as Good as we Think?” Theriogenology 69 (1): 2–9. doi:10.1016/j.theriogenology.2007.09.030.
  • Wewering, F., F. Jouy, D. K. Wissenbach, S. Gebauer, M. Blüher, R. Gebhardt, R. Pirow, M. Von Bergen, S. Kalkhof, and A. Luch. 2016. “Characterization of Chemical-Induced Sterile Inflammation in Vitro: Application of the Model Compound Ketoconazole in a Human Hepatic co-Culture System.” Archives of Toxicology 91: 1–12. doi:10.1007/s00204-016-1686-y.
  • Wiemann, M., A. Vennemann, U. G. Sauer, K. Wiench, L. Ma-Hock, and R. Landsiedel. 2016. “An in Vitro Alveolar Macrophage Assay for Predicting the Short-Term Inhalation Toxicity of Nanomaterials.” Journal of Nanobiotechnology 14 (1): 16. doi:10.1186/s12951-016-0164-2.
  • Wiemann, M., A. Vennemann, M. Stintz, R. R. Retamal Marin, F. Babick, G. G. Lindner, T. B. Schuster, U. Brinkmann, and N. Krueger. 2018. “Effects of Ultrasonic Dispersion Energy on the Preparation of Amorphous SiO(2) Nanomaterials for in Vitro Toxicity Testing.” Nanomaterials 9 (1): 11. doi:10.3390/nano9010011.
  • Xia, T., R. F. Hamilton, J. C. Bonner, E. D. Crandall, A. Elder, F. Fazlollahi, T. A. Girtsman, et al. 2013. “Interlaboratory Evaluation of in Vitro Cytotoxicity and Inflammatory Responses to Engineered Nanomaterials: The NIEHS Nano GO Consortium.” Environmental Health Perspectives 121 (6): 683–690. doi:10.1289/ehp.1306561.
  • Zhang, B., and S. Horvath. 2005. “A General Framework for Weighted Gene co-Expression Network Analysis.” Statistical Applications in Genetics and Molecular Biology 4 (1): Article17.
  • Zhang, H., Z. Ji, T. Xia, H. Meng, C. Low-Kam, R. Liu, S. Pokhrel, et al. 2012. “Use of Metal Oxide Nanoparticle Band Gap to Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation.” ACS Nano 6 (5): 4349–4368. doi:10.1021/nn3010087.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.